Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy
Titel:
Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy
Auteur:
Barratt, Jonathan Lafayette, Richard Kristensen, Jens Stone, Andrew Cattran, Daniel Floege, Jürgen Tesar, Vladimir Trimarchi, Hernán Zhang, Hong Eren, Necmi Paliege, Alexander Rovin, Brad H.